TFX Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

132.600

Open

131.350

VWAP

130.86

Vol

557.71K

Mkt Cap

5.77B

Low

129.710

Amount

72.98M

EV/EBITDA(TTM)

22.44

Total Shares

44.27M

EV

8.08B

EV/OCF(TTM)

115.36

P/S(TTM)

2.71

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Show More

Events Timeline

(ET)

2026-05-07

07:20:00

Sees 2026 Revenue Growth of 14.4%-15.4%

2026-05-07

07:20:00

Teleflex Reports Q1 Revenue of $548.3M, Beating Consensus

2026-04-30 (ET)

2026-04-30

07:20:00

Teleflex Appoints Jason Weidman as New CEO

2026-04-21 (ET)

2026-04-21

19:30:00

U.S. Indices Retreat as Energy Sector Gains

2026-04-21

18:00:00

CVC and GTCR Considering Teleflex Takeover

News

CNBC

Baupost Group Increases Amazon Stake Amid AI Rally

seekingalpha

05-07seekingalpha

Teleflex Q1 2026 Earnings Call Insights and Strategic Outlook

Newsfilter

05-07Newsfilter

Teleflex Q1 Financial Results: Revenue Up 32.3%

seekingalpha

05-06seekingalpha

Teleflex Q1 Earnings Announcement Scheduled

seekingalpha

04-30seekingalpha

Teleflex Appoints New CEO to Drive Strategic Growth

Newsfilter

04-30Newsfilter

Teleflex Appoints New CEO to Drive Growth

7 Analyst Rating

Wall Street analysts forecast TFX stock price to rise

1 Buy

5 Hold

1 Sell

Hold

Current: 0.000

Low

122.00

Averages

136.20

High

155.00

Current: 0.000

Low

122.00

Averages

136.20

High

155.00

Raymond James

Jayson Bedford

NULL

to

Outperform

maintain

$128 -> $150

AI Analysis

2026-05-08

Reason

Raymond James

Jayson Bedford

Price Target

$128 -> $150

AI Analysis

2026-05-08

maintain

NULL

to

Outperform

Reason

Raymond James analyst Jayson Bedford raised the firm's price target on Teleflex to $150 from $128 and keeps an Outperform rating on the shares. The Q1 results were "encouraging," the analyst tells investors in a research note.

Mizuho

Neutral

maintain

$135 -> $140

2026-05-08

Reason

Mizuho

Price Target

$135 -> $140

2026-05-08

maintain

Neutral

Reason

Mizuho raised the firm's price target on Teleflex to $140 from $135 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TFX

Unlock Now

Valuation Metrics

The current forward P/E ratio for Teleflex Inc (TFX.N) is 19.88, compared to its 5-year average forward P/E of 16.76. For a more detailed relative valuation and DCF analysis to assess Teleflex Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

16.76

Current PE

19.88

Overvalued PE

22.96

Undervalued PE

10.57

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

16.37

Current EV/EBITDA

15.34

Overvalued EV/EBITDA

26.81

Undervalued EV/EBITDA

5.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

3.56

Current PS

2.40

Overvalued PS

4.96

Undervalued PS

2.17

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

best 3 stock for swingtrading right now

Intellectia · 429 candidates

Price: $5.00 - $150.00Moving Average Relationship: PriceAboveMA20Month Price Change Pct: $5.00 - $30.00One Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Borr Drilling Ltd

1.84B

Teekay Tankers Ltd

2.63B

Teleflex Inc

5.11B

Edgewell Personal Care Co

967.94M

vTv Therapeutics Inc

150.66M

Match Group Inc

7.43B

suggest short term stocks for this week

Intellectia · 37 candidates

Market Cap: >= 5.00BRegion: USPrice: $15.00 - $120.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $25.00Monthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

Unity Software Inc

8.42B

Alcoa Corp

15.41B

Chewy Inc

10.88B

Dow Inc

29.29B

Summit Therapeutics Inc

12.86B

LyondellBasell Industries NV

25.92B

Whales Holding TFX

Abrams Bison Investments, L.L.C.

Invenomic Capital Management LP

Soleus Capital Management, L.P.

Heartland Advisors, Inc.

Empyrean Capital Partners, LP

HBK Investments L.P.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Teleflex Inc (TFX) stock price today?

The current price of TFX is 130.28 USD — it has increased 0.18

What is Teleflex Inc (TFX)'s business?

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

What is the price predicton of TFX Stock?

Wall Street analysts forecast TFX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TFX is136.20 USD with a low forecast of 122.00 USD and a high forecast of 155.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Teleflex Inc (TFX)'s revenue for the last quarter?

Teleflex Inc revenue for the last quarter amounts to 548.26M USD, increased 32.35

What is Teleflex Inc (TFX)'s earnings per share (EPS) for the last quarter?

Teleflex Inc. EPS for the last quarter amounts to -0.18 USD, decreased -108.70

How many employees does Teleflex Inc (TFX). have?

Teleflex Inc (TFX) has 15500 emplpoyees as of May 15 2026.

What is Teleflex Inc (TFX) market cap?

Today TFX has the market capitalization of 5.77B USD.